1. Introduction {#sec1}
===============

Homeostatic maintenance of energy balance is crucial for health. In the brain, specialized neuronal circuits integrate metabolic signals related to energy stores and needs and consequently adjust energy intake, utilization and expenditure [@bib1]. The melanocortin system is one of the most well described circuits which control body weight and food intake [@bib2; @bib3]. The two main antagonistic components of this system are the anorexigenic POMC and orexigenic NPY neurons located in the arcuate nucleus of the hypothalamus. It has been recently shown that density and input type on POMC and NPY neurons vary in adult mice, depending on the metabolic state and the associated fluctuation of circulating hormones [@bib4; @bib5; @bib6]. Such synaptic plasticity modifies the activity of these neurons and thereby the responsiveness of the melanocortin system. It has been proposed that the synaptic plasticity of this system in response to acute changes in fuel availability was essential to the accurate control of food intake and the maintenance of body weight in adulthood [@bib7; @bib8; @bib9]. Moreover, altered synaptic plasticity of POMC and NPY neurons was found in diet-induced obese rodents suggesting that inability to dynamically rewire feeding circuits could contribute to obesity [@bib10].

Polysialic acid (PSA) is a cell-surface glycan that modulates cell-to-cell interactions [@bib11]. Polysialylation of cell adhesion proteins is involved in various synaptic plasticity-dependent processes in the central nervous system including learning [@bib12; @bib13], pain modulation [@bib14; @bib15] and the control of neuroendocrine functions [@bib16; @bib17]. We previously reported that polysialylation was also required for the adaptive synaptic plasticity of feeding circuits during acute positive energy balance [@bib8]. Precisely, high-fat diet (HFD) given for three days caused a PSA-dependent increase in the excitatory inputs connecting POMC neurons in mice. The polysialyltransferase PST-1, encoded by the *St8sia4* gene was identified as the enzyme involved in the PSA-dependent control of energy intake [@bib8]. However the biological mediators and the intracellular cascade of events leading to the dietary fat-induced PSA-dependent synaptic plasticity in the hypothalamus have not been characterized yet.

It is now clearly established that modifications in gene expression patterns are required to elicit structural and functional synaptic plasticity in response to experience and environmental cues [@bib18; @bib19; @bib20]. The molecular mechanisms supporting these changes in gene expression were explored in several synaptic plasticity-dependent processes such as learning, memory formation, addiction and stress [@bib21; @bib22; @bib23]. In these models, alterations in expression, localization or activity of transcription regulatory factors and in chromatin structure are instrumental in the signaling pathway leading to synapse remodeling [@bib23; @bib24]. In particular, changes in the acetylation of histone tails and in the activity of histone acetyltransferases or histone deacetylases are associated with changes in plasticity-related gene expression in the brain areas supporting these synaptic plasticity-dependent processes, i.e. the hippocampus, the prefrontal cortex and the nucleus accumbens [@bib25; @bib26; @bib27; @bib28]. Such mechanisms are still unexplored regarding the synaptic plasticity of the feeding circuits.

Here we explored the role of hypothalamic polysialylation in the long-term maintenance of body weight. We also deciphered the molecular sequence underlying the activation of polysialylation in the hypothalamus upon overfeeding. Hypothalamic PSA removal and *St8sia4* silencing increased body weight gain on HFD, indicating that *St8sia4* is essential to maintain energy homeostasis. We showed that dietary fat rapidly incited post-translational histone modifications on the *St8sia4* gene in the mediobasal hypothalamus (MBH). The histone acetyltransferase MOF was required for the HFD-induced acetylation of histone H4 on lysine 16 and the subsequent activation of *St8sia4* gene transcription. Moreover, *Mof* silencing in the MBH of adult mice fed a HFD reduced hypothalamic PSA levels, caused overfeeding and exacerbated diet-induced obesity.

2. Materials and methods {#sec2}
========================

2.1. Animals and animal procedures {#sec2.1}
----------------------------------

Experiments were carried out on 8-week-old male C57Bl/6JOla mice (Harlan Laboratories). Animal care and experimental procedures were performed with approval from the Animal Care and Use Committee of the University of Burgundy. Mice were housed in individual cages and maintained on a standard light/dark cycle. They were fed either a standard diet (A04; Safe Laboratories) or a high fat diet (HFD) (Safe Laboratories as previously described [@bib8]). All animals had ad libitum access to food and water. Body weight and food consumption were recorded every day.

2.2. Repeated bilateral injection of endoneuraminidase N into the mediobasal hypothalamus {#sec2.2}
-----------------------------------------------------------------------------------------

Mice were anesthetized with isoflurane (Abbott) and placed in a stereotaxic apparatus (David Kopf Instruments) in flat skull position. After dermal disinfection with betadine solution, the skin and cranial muscles were incised and the skull was exposed. Small holes were drilled and a double cannula with a cap (C235G-0.8/SP 4.6 mm; Plastic One) was inserted to target above the mediobasal hypothalamus (MBH) using the following coordinates: −1.4 mm posterior to the Bregma, ±0.4 mm lateral to the sagittal suture, and −4.6 mm below the skull surface ([Supplementary Figure 1A](#appsec2){ref-type="sec"}). Cannula was fixed with screws and dental cement. After cannulation, animals were kept under controlled temperature and rehydrated with intraperitoneal injections of physiological fluid. Mice were then housed individually and were allowed 1 week for recovery before experiment. For injection, mice were anesthetized with isoflurane, and cannula cap was removed. Mice were injected with either vehicle or Endoneuraminidase N (EndoN, 0.28 units/side, 400 nL; Eurobio) at a rate of 100 nL/min, weekly during one month, with a 5.6 mm injector (C235I/SP 5.6 mm; Plastic One) inserted into the cannula targetting the MBH. The injector was maintained for an additional 3 min to avoid back leakage. After injection, mice were replaced in their individual cages.

2.3. Bilateral injection of lentiviral vectors into the hypothalamus {#sec2.3}
--------------------------------------------------------------------

Mice were anesthetized with isoflurane (Abbott) and placed in a stereotactic apparatus (David Kopf Instruments). Mice received a bilateral injection of lentiviral transduction particles (400 nL per side, 2--3 × 10^9^ TU/mL), using the following stereotactic coordinates: −1.4 mm posterior to the Bregma, ±0.4 mm lateral to the sagittal suture, and −5.6 mm below the skull surface ([Supplementary Figure 1B](#appsec2){ref-type="sec"}). The lentiviral particles contained either a non-target control shRNA (Non-mammalian Control; Sigma--Aldrich), or a shRNA targeting *Mof* (TRCN0000039323; Sigma--Aldrich) or *St8sia4* (TRCN0000093936). The viral suspension was delivered at a rate of 100 nL/min through a 34G blunt needle mounted on a 10 μL syringe (NanoFil device from WPI) controlled by a micropump (UMP2 from WPI). After surgery, animals were rehydrated with intraperitoneal injection of saline. Mice were also injected with analgesic (buprenorphine; 0.1 mg/kg i.p.; Buprecare, Animalcare) and ibuprofen (20 mg/kg; Advil) was added to the drinking water for 3 days. All experiments were initiated after a 3-week recovery period.

2.4. EchoMRI {#sec2.4}
------------

Nuclear magnetic resonance was used to determine the body composition of the mice (QNMR system EchoMRI-500T, Echo Medical Systems).

2.5. Chromatin immunoprecipitation {#sec2.5}
----------------------------------

Brains were promptly removed and the mediobasal hypothalamic regions dissected using brain matrices. Explants were immediately cross-linked in 1.5% formaldehyde for 10 min at room temperature and quenched by adding glycine to a final concentration of 0.125 M. Explants were then washed 3 times in ice-cold PBS. Tissues were first homogenized in a cell lysis buffer containing 50 mM Hepes pH 7.5, 140 mM NaCl, 1 mM EDTA, 10% Glycerol, 0.5% NP-40 and 0.25% Triton X-100, 1× Complete protease inhibitors cocktail (Roche). The pellets were finally resuspended in a nuclear lysis buffer (Tris--HCl 10 mM, NaCl 140 mM, EDTA 1 mM, EGTA 0.5 mM, 0.1% SDS, 0.1% Na Deoxycholate), 1× Complete protease inhibitors cocktail (Roche) and sonicated for 20 min in a Bioruptor (Diagenode; settings: High; 30 s ON/30 s OFF). This chromatin-shearing protocol produces fragments ranging from 150 to 400 bp in length. For ChIP, antibodies (listed in [Table 1](#tbl1){ref-type="table"}) were conjugated to magnetic Dynabeads (Invitrogen). Chromatin was incubated with beads-bound antibodies overnight at 4 °C in a buffer containing Tris--HCl 10 mM, NaCl 140 mM, EDTA 1 mM, EGTA 0.5 mM, 0.1% SDS, 0.5% Na Deoxycholate, 1% NP-40 and 1× Complete protease inhibitors cocktail (Roche) and then washed 6 times in RIPA buffer and once in Tris--EDTA Buffer (Tris 10 mM, EDTA 1 mM). Elution buffer (Tris 50 mM, EDTA 10 mM, SDS 1%) was added and samples were incubated at 65 °C, 1400 rpm, in a Thermomixer for 30 min to remove beads. Chromatin in the supernatant was then reverse cross-linked by incubating 10 h at 65 °C. DNA was purified with a QIAquick PCR purification kit (Qiagen). Quantitative PCR analysis was performed using the FAST SYBR Green Master Mix (Applied Biosystems). The following primers were used for PCR amplification: were as follow: 5′-GCCAGTAACGCAAGGCAACA-3′ and 5′-CGTAGCAGGGAAACGATAAG-3′ for *St8sia4* and 5′-TCTGGCTCAGCTCAGTCTCC-3′ and 5′-GCTTTTCCTGCCCGAGA-3′ for *St8sia2*. Quantification was performed with a standard curve method, using input DNA for normalization.

2.6. Total RNA extraction, RT and qPCR analysis {#sec2.6}
-----------------------------------------------

Quantitative PCR analysis was performed using inventoried TaqMan Gene Expression Assays and the TaqMan FAST Universal PCR Master Mix (Applied Biosystems). TaqMan assay IDs for the mRNA analyzed were as follow: Mm00458911_m1 for *Mof*, Mm01292231_m1 for *St8sia4*, Mm00456815_m1 for *Ncam1*, Mm00456289_m1 for *St8sia2*, Mm00450174_m1 for *Gne*, Mm02342429_g1 for *Ppia*. For each reaction, 1 μl of a 1:10 dilution of the RT product was used in a final volume of 10 μl and each sample was assayed in triplicate. PCR amplification was run on a StepOne Plus RealTime PCR System (Applied Biosystems) and the StepOne Gene Expression Software was used for gene expression analysis. Quantification was done using the comparative Ct method and *Ppia* was used for normalization.

2.7. PSA ELISA assay {#sec2.7}
--------------------

Brains were promptly removed and the mediobasal hypothalamic regions dissected. Tissue lysis was performed in RIPA lysis buffer using the TissueLyser system (Qiagen) and 5 mm stainless steel beads (Qiagen). Homogenates were then centrifuged 5 min at 5000 *g* and supernatants were collected for PSA assay using an enzyme-linked immunosorbent assay kit (PSA NCAM ELISA kit; Eurobio). Total protein concentration was determined using the Protein Assay Kit ll (Bio-Rad).

2.8. Statistical analysis {#sec2.8}
-------------------------

All data are displayed as mean ± SEM. Equality of variances and normality of distribution were checked prior to analysis. Data sets with two independent groups with similar variances were analyzed for statistical significance using an unpaired two-tailed Student\'s *t* test. Otherwise, a Mann Whitney test was applied. Data sets with more than two groups were analyzed using one-way analysis of variance (ANOVA) followed by a Dunnett\'s post-hoc test. For statistical analyses in [Figure 6](#fig6){ref-type="fig"}C and E, a two-way ANOVA was performed. All *p* values below 0.05 were considered significant. Significant differences were indicated as follow: \**p* \< 0.05, \*\**p* \< 0.01, and \*\*\**p* \< 0.001.

3. Results {#sec3}
==========

3.1. PSA removal in the hypothalamus accelerates the onset of DIO {#sec3.1}
-----------------------------------------------------------------

To assess the role of hypothalamic polysialylation in the long-term maintenance of body weight of mice on HFD, we generated PSA-depleted mice. We used endoneuraminidase N (endoN), a bacterial enzyme that specifically removes PSA residues from cell adhesion molecules [@bib29]. EndoN remains active at least eight days after a single injection in the brain parenchyma [@bib8]. We chronically depleted PSA in this area by bilateral intraparenchymal injections of endoN once a week during one month in mice fed with HFD ([Figure 1](#fig1){ref-type="fig"}A). The effect of the drug was checked by post-mortem analysis. We observed that the repeated injections of endoN reduced by 80--90% the PSA level in the MBH ([Figure 1](#fig1){ref-type="fig"}B). The repeated injections of endoN did not modify body weight in mice fed a standard diet for one month ([Figure 1](#fig1 fig1){ref-type="fig"}C--E, and [Supplementary Figure 2](#appsec2){ref-type="sec"}). However, the persistent loss of hypothalamic PSA caused by endoN dramatically increased the weight gain of mice on HFD, in comparison to vehicle-treated mice ([Figure 1](#fig1){ref-type="fig"}C). As a result, body weight gain and fat mass measured after one month in mice on HFD were higher in endoN-treated mice relative to vehicle-treated mice ([Figure 1](#fig1){ref-type="fig"}D and E). Thus, PSA removal in the hypothalamus accelerated the onset of DIO in mice.

3.2. Reduction of polysialylation in the hypothalamus increases the body weight gain on HFD {#sec3.2}
-------------------------------------------------------------------------------------------

PST-1 is the major polysialyltransferase in adult hypothalamus [@bib30; @bib31]. To test whether hypothalamic PST-1 is involved in the long-term maintenance of body weight, we examined the metabolic consequences of *St8sia4* knock-down in the hypothalamus of mice fed a HFD. We used lentiviral vectors-mediated RNA interference for specifically knocking down *St8sia4* expression in the hypothalamus of adult mice. Control mice received lentiviral vectors carrying a shRNA sequence directed against a non-mammalian target. Three weeks after surgery, *St8sia4* mRNA level was reduced by 21% in *St8sia4* knock-down (KD) animals (PST-1 KD^MBH^) mice compared to control mice ([Figure 2](#fig2){ref-type="fig"}A). The expression of *St8sia2*, *Ncam*, and *Gne* was not altered ([Figure 2](#fig2){ref-type="fig"}A), indicating that the RNAi-mediated knockdown of *St8sia4* was specific and did not modify expression of other genes involved in the signaling pathway of PSA. Body weight gain and energy intake of control and PST-1 KD^MBH^ mice fed a standard diet for 2 months were similar ([Supplementary Figure 3](#appsec2){ref-type="sec"}). To investigate whether a reduction of polysialylation in the hypothalamus increased the vulnerability to DIO, PST-1 KD^MBH^ mice were fed a HFD for two months. In these mice, knock-down efficiency was determined by post-mortem analysis of PSA level in MBH biopsies. Only mice with more than 5% reduction of hypothalamic PSA were further analyzed, considering otherwise that we failed to target the MBH. After screening, we detected a significant reduction of the PSA level by 25.7% in the MBH of PST-1 KD^MBH^ mice, in comparison to control mice ([Figure 2](#fig2){ref-type="fig"}B). A retrospective analysis showed that PST-1 KD^MBH^ mice gained progressively more weight during the 2-month HFD than control mice ([Figure 2](#fig2){ref-type="fig"}C). Body weight gain and adiposity of PST-1 KD^MBH^ mice on HFD were therefore significantly increased ([Figure 2](#fig2){ref-type="fig"}D and E). Thus, a limited polysialylation in the hypothalamus accelerated the onset of DIO.

3.3. Short-term HFD activates the transcription of the *St8sia4* gene in the MBH {#sec3.3}
--------------------------------------------------------------------------------

We next investigated the regulation of *St8sia4* expression in the hypothalamus of HFD-fed mice. We determined if HFD exposure triggered chromatin remodeling and transcriptional activation of the *St8sia4* gene in the MBH. Chromatin modifications were analyzed on the promoter of *St8sia4* by ChIP with chromatin extracts obtained from the MBH of mice fed a HFD for 24 h--72 h ([Figure 3](#fig3){ref-type="fig"} and [Supplementary Figure 4](#appsec2){ref-type="sec"}). After 24 h on HFD, an increase in H3 and H4 acetylation and a decrease in H4 methylation were observed ([Figure 3](#fig3){ref-type="fig"}A; 2.25, 1.86 and 1.83 fold for H3K14Ac, H4K16Ac and H4K20Me respectively). The levels of H4K16Ac, H4K20Me and H3K14Ac returned to basal values after 72 h on HFD, indicating that these post-translational modifications were transient ([Supplementary Figure 4B](#appsec2){ref-type="sec"}). HFD feeding for 48 h triggered a dissociation of histones H3 and H4 from the promoter of this gene ([Figure 3](#fig3){ref-type="fig"}B; 1.66 fold and 1.74 fold decrease respectively). The decrease in histone interaction with *St8sia4* promoter preceded an increase in Pol2-S5P level -the activated form of RNA polymerase II- indicating an activation of *St8sia4* transcription ([Figure 3](#fig3){ref-type="fig"}B). *St8sia4* mRNA levels were also significantly higher after 3 days on HFD ([Figure 3](#fig3){ref-type="fig"}C). Additional analysis revealed no post-translational histone modifications, no histone dissociation and no change in RNA polymerase II phosphorylation on the promoter of the *St8sia2* gene, encoding the PST-2 polysialyltransferase ([Supplementary Figure 4C and 4D](#appsec2){ref-type="sec"}). The chromatin remodeling events detected in the MBH after HFD introduction were thus specific to the *St8sia4* polysialyltransferase gene.

3.4. Short-term HFD elicits the recruitment of the histone acetyltransferase MOF on the *St8sia4* promoter in the MBH {#sec3.4}
---------------------------------------------------------------------------------------------------------------------

In order to identify the histone acetyltransferases (HAT) that trigger the increase in histone acetylation and the subsequent activation of *St8sia4* transcription in the MBH of HFD-fed mice, the recruitment of CBP, GCN5, MOF and TIP60 was analyzed by ChIP. These HATs are representative members of the 3 different families of histone lysine acetyltransferases and are known to acetylate either H3K14 or H4K16 or both [@bib32; @bib33; @bib34]. Their interaction with *St8sia4* was analyzed in MBH chromatin extracts from mice fed a HFD for 6 h or 10 h ([Figure 4](#fig4){ref-type="fig"}). After 6 h on HFD, a 2.20 fold increase in MOF was detected on *St8sia4* promoter. This increase was persistent after 10 h of HFD exposure. At this time point, GCN5 was also recruited. The early recruitment of MOF suggested that this HAT plays a critical role in mediating the effects of HFD on the activation of *St8sia4* transcription in the MBH.

3.5. MOF is required for HFD-induced transcription of the *St8sia4* gene and the associated PSA synthesis in the MBH {#sec3.5}
--------------------------------------------------------------------------------------------------------------------

To determine the role of MOF in HFD-induced hypothalamic polysialylation, we knocked down MOF in the hypothalamus and tested whether *St8sia4* transcription and PSA levels could still be increased upon HFD exposure. Lentiviral particles containing a MOF-targeting shRNA sequence were stereotactically injected in the MBH of adult mice. Control mice were injected with lentiviral particles containing a non-mammalian target shRNA. After 3 weeks of recovery, a 26.73% decrease in *Mof* mRNA level was detected in the hypothalamus of silenced mice (MOF KD^MBH^ mice) ([Figure 5](#fig5){ref-type="fig"}A). Since H4K16Ac has been identified as the main substrate of MOF in many cell types and organisms [@bib32; @bib35; @bib36; @bib37], we tested whether *Mof* knock-down altered the HFD-induced increase in H4K16Ac level on *St8sia4* in the MBH ([Figure 5](#fig5){ref-type="fig"}B). After 24 h of HFD feeding, the level of H4K16Ac on *St8sia4* was reduced by 25.39% in MOF KD^MBH^ mice in comparison to control mice. The level of H4K16Ac in HFD-fed MOF-KD^MBH^ mice was similar to the level in standard-diet fed mice ([Figure 3](#fig3){ref-type="fig"}A), indicating that *Mof* knock-down abolished the HFD-induced acetylation of H4K16. After 3 days on HFD, the level of Pol2-S5P detected on *St8sia4* was strongly reduced in MOF-KD^MBH^ mice in comparison to the control group (38.33% reduction, [Figure 5](#fig5){ref-type="fig"}C). Again, Pol2-S5P level in MOF-KD^MBH^ mice was similar to the level in standard-diet fed mice ([Figure 3](#fig3){ref-type="fig"}B). We finally assessed polysialylation capacities in MOF-KD^MBH^ mice by measuring both *St8sia4* mRNA level and PSA level in the MBH after exposure to HFD for 3 days ([Figure 5](#fig5){ref-type="fig"}C and D). *St8sia4* mRNA level was reduced by 38.73% and PSA level was reduced by 14.10% in MOF-KD^MBH^ mice. Altogether, these results indicated that MOF is crucial for activating the polysialylation pathway in the MBH in response to HFD.

3.6. MOF-depleted mice are prone to obesity {#sec3.6}
-------------------------------------------

We finally examined the consequences of MOF knock-down on the PSA-dependent short-term feeding response to HFD and the long-term regulation of body weight on HFD. The short-term feeding response to HFD was assessed over 8 days of HFD exposure. When fed a standard diet, control and MOF KD^MBH^ mice displayed similar body weight and daily energy intake ([Figure 6](#fig6){ref-type="fig"}A and B). In both control and MOF KD^MBH^ mice, HFD caused a transient increase in energy intake ([Figure 6](#fig6){ref-type="fig"}C). However the normalization of energy intake was slightly but significantly altered in MOF KD^MBH^ mice. Consequently, the cumulative energy intake of MOF KD^MBH^ mice during the first week of HFD was higher in this group ([Figure 6](#fig6){ref-type="fig"}D). HFD feeding revealed an alteration of the homeostatic control of food intake in MOF KD^MBH^ mice. To assess the role of MOF in the long-term regulation of energy homeostasis, control and MOF KD^MBH^ mice were fed a HFD for 8 weeks. Food intake and body weight were recorded daily during this period. Only mice with more than 5% reduction of hypothalamic *Mof* mRNA level were further analyzed, considering otherwise that we failed to target the MBH. As a reference, body weight of control and MOF KD^MBH^ mice fed a standard diet was measured over 6 weeks after surgery. No significant differences were observed in body weight gain between control mice and MOF KD^MBH^ mice (+2.49 ± 0.28 g vs 2.96 ± 0.52 g). However, upon HFD, a dramatic increase in body weight was observed in MOF KD^MBH^ mice ([Figure 6](#fig6){ref-type="fig"}E). The body weight gain of MOF KD^MBH^ mice over the 8 weeks of HFD was 31.85% higher than the one of the control group ([Figure 6](#fig6){ref-type="fig"}F). This increase in body weight gain was due to an increase in fat mass in MOF KD^MBH^ mice ([Figure 6](#fig6){ref-type="fig"}G). The higher cumulative energy intake of MOF KD^MBH^ mice in comparison to control mice over the 8-week period likely explained this phenotype ([Figure 6](#fig6){ref-type="fig"}H, MOF KD^MBH^ mice: 786.83 ± 14.06 kcal and control mice: 708.41 ± 21.79 kcal).

4. Discussion {#sec4}
=============

Obesity is on the rise in both developed and developing countries, and it is now considered as a worldwide epidemic [@bib38]. It has been proposed that obesity could be a brain disease [@bib39], and recently, several molecular brain targets of therapeutic interest have been identified [@bib40]. Investigation of central regulatory pathways involved in the control of appetite and body weight could probably help with the fight against obesity. We previously identified polysialylation as an essential process in the nutritionally regulated synaptic plasticity of the melanocortin system [@bib8]. We now show that polysialylation is essential to the long-term regulation of body weight. We found that a defect in polysialylation may be a primary cause of obesity. Furthermore, the experimental data presented here unveil an unexpected role for the histone acetyltransferase MOF in the brain control of energy balance.

Developmental malformation of the melanocortin system, i.e. disruption of neural projection pathways within the hypothalamus, could contribute to the obese phenotype and related metabolic disorders [@bib41]. Moreover, the wiring of arcuate POMC neurons of rats kept on standard diet predicts vulnerability to weight gain on HFD, suggesting that accurate connectivity in this neuronal system is crucial to maintain energy homeostasis [@bib10]. Besides, an abnormal synaptic organization of feeding circuits that can be acutely reversed by hormonal or pharmacological treatments has been found in obese mice and rats [@bib42; @bib43]. Thus, it has been suggested that the altered synaptic plasticity in feeding circuits, in addition to steady neuroanatomical defects, might promote DIO [@bib44]. Nevertheless, whether synaptic inadequacy is cause or consequence of the metabolic imbalance is still not clear [@bib9]. Here, we report that the lack of hypothalamic PSA strongly accelerated the onset of DIO in mice. Given the role of PSA in synaptic plasticity, our results suggest that the inflexibility of feeding circuits is a risk factor for obesity. This is in line with the well-documented adaptive function of the plasticity in feeding circuits in response to metabolic fluctuations [@bib4; @bib6].

The removal of hypothalamic PSA was sufficient to cause severe overweight in mice fed a HFD for 1--2 months, suggesting that the inability to properly rewire feeding circuits depending on the nutritional conditions, makes mice prone to obesity. Since the human hypothalamus is able to undergo hormone-dependent structural plasticity [@bib45], our findings could be relevant to the etiology of obesity in humans as well. Indeed, large-scale studies on the genetic determinants of body mass index have revealed the strong influence of some genes involved in neuronal plasticity [@bib46; @bib47]. Interestingly, the polymorphism in *Negr1*, the gene coding the neuronal growth regulator 1, a cell adhesion molecule involved in the brain remodeling, seems to be causal in high body weight [@bib47]. Moreover, genetic defects reducing the levels of plasticity-related molecules such as the brain-derived neurotrophic factor (BDNF) or its receptor TrkB cause severe early-onset obesity [@bib48; @bib49]. Therefore, it is conceivable that an altered synaptic plasticity could predispose humans to obesity.

To gain insight into the molecular sequence underlying the synaptic plasticity-dependent control of energy balance, we explored the chromatin remodeling events underlying the activation of the *St8sia4* gene expression upon high fat diet (HFD). We found that the HFD induced a decrease in the level of monomethylated H4K20 and an increase in acetylation of histones H3K14 and H4K16 on the *St8sia4* gene. In mammals, histones localized in silent heterochromatic regions are usually characterized by high levels of methylation at certain specific sites and low levels of acetylation [@bib50]. H4K20Me1 marks are mostly found in regions of facultative heterochromatin and H4K20 demethylation has been associated with transcription activation in different models [@bib51; @bib52; @bib53]. Both H3K14 and H4K16 acetylation impact chromatin structure and allow switching from a repressive state to a transcriptionally active state [@bib54; @bib55; @bib56; @bib57]. In our study, the decrease in H4K20Me1 and the increase in H3 and H4 acetylation upon HFD were followed by their dissociation. The level of RNA polymerase II phosphorylated on the serine 5 of the carboxy-terminal domain increased subsequently. Moreover, the phosphorylation of the serine 5 of the RNA polymerase II is acquired during the transcription initiation phase [@bib58]. Altogether, our results clearly demonstrate that HFD triggers an activation of *St8sia4* transcription.

Tracing back the signaling cascade leading to the activation of *St8sia4* transcription, we identified two histone acetyltransferases, GCN5 and MOF, recruited on *St8sia4* within the few hours following the introduction of HFD. Transcription activation relies on cross-regulation of histone post-translational modifications through the stepwise or concomitant recruitment of histone modifying enzymes [@bib59]. Of note, H3K14 and H4K16 are major acetylation targets for GCN5 and MOF, respectively [@bib32; @bib35; @bib37; @bib55; @bib60]. Additionally, MOF depletion in drosophila or human cells resulted in a genome-wide loss of H4K16Ac [@bib32; @bib37; @bib61; @bib62]. In our study, we did not investigate interactions of histone demethylases with *St8sia4* promoter. However, PHF8 is the only histone H4K20Me1 demethylase identified up to now and its activity is associated with a positive regulation of gene expression [@bib52]. PHF8 could thus contribute, in cooperation with GCN5 and MOF to the activation of *St8sia4* transcription in the hypothalamus upon high fat feeding.

In our study, since MOF recruitment was already detected after 6 h of HFD feeding, we focused on the function of this HAT in the activation of *St8sia4* expression upon HFD exposure. The depletion of MOF in the MBH completely abolished the HFD-induced increase in H4K16 acetylation on *St8sia4* and the subsequent recruitment of the RNA polymerase II on this gene. The early recruitment of MOF on *St8sia4* upon HFD exposure, the absence of activation of *St8sia4* transcription and the decrease in PSA level after MOF knock-down strongly suggested a crucial role for MOF in mediating the effect of HFD exposure on the establishment of PSA-dependent synaptic plasticity in the hypothalamus. MOF KD^MBH^ mice displayed an impairment of the short-term feeding response to HFD, which is actually a PSA-dependent process [@bib8]. In addition, we show that MOF KD^MBH^ mice displayed a higher propensity to develop DIO. Reducing polysialylation by *St8sia4* silencing or PSA removal from the hypothalamus accelerated the onset of a DIO phenotype as well. MOF was originally identified as required for dosage compensation in Drosophila [@bib63; @bib64]. Afterwards, studies performed on mammalian cells and tumor biopsies indicated that MOF is crucial to several cell functions such as cell proliferation and differentiation, DNA damage repair, autophagy and tumorigenesis [@bib65; @bib66; @bib67]. In vivo, a Purkinje cells-specific deletion of MOF in the cerebellum produced neurological abnormalities including impaired motor coordination, ataxia and a backward-walking phenotype [@bib68]. The present work demonstrates that mediobasal hypothalamic MOF is involved in the regulation of energy homeostasis through an activation of polysialylation. Whereas some studies suggest that MOF is globally involved in the activation of transcription, others indicate that this HAT rather activates defined subset of genes and has a function in transcription regulation in specific cell types only [@bib32; @bib35; @bib37; @bib69; @bib70]. Though we cannot rule out that a larger MOF-dependent transcriptomic program contributes to the accelerated onset of diet-induced obesity in MOF-depleted mice, the subsequent deficit in hypothalamus polysialylation capacities of these mice might largely contribute to their increased vulnerability to DIO.

In few recent studies, MOF has been detected in enhancer regions on mammalian genes [@bib71; @bib72]. In addition, interactions of MOF with transcription factors have been identified. For instance, MOF is recruited to FOXP3-target genes by directly interacting with FOXP3 and the transcription factor p53 is an acetylation target of MOF [@bib73; @bib74]. This suggests that MOF could be recruited to the *St8sia4* gene by interacting directly with a transcription factor activating *St8sia4* transcription upon high fat feeding. Otherwise, its recruitment could involve Mediator complex which is known to convey regulatory information to the basal RNA polymerase II transcription machinery by interacting both with gene-specific transcription factors and with histone modifying enzymes [@bib75; @bib76]. The mechanism by which MOF is targeted to *St8sia4* upon HFD feeding remains to be determined.

In conclusion, the present work clearly indicated the causal role of altered PSA signaling in accelerating the development of obesity. Given the role of PSA in the modulation of cell-to-cell interactions these findings strengthen the concept that individual capacity to synaptic plasticity is a key factor in the development of overweight with obesogenic foods [@bib10; @bib44].
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Appendix A. Supplementary data {#appsec2}
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The following are the Supplementary data related to this article:Supplementary Figure 1Traces of injectors in stained brain sections. A. Traces of the cannula guide (CG) and the injectors (I) used for repeated injections of EndoN in the MBH. Injectors were inserted at −5.6 mm below the skull surface. Note that the permanent cannula guide was shorter than the injectors to minimize injury. The injectors were labeled with DiI (in yellow) to visualize their traces. Slides were stained with DAPI (in blue) to reveal nuclei. B. Traces of the nanofil (NF) used for single injection of lentiviral particles in the MBH. Nanofil was inserted at −5.6 mm below the skull surface. Slides were stained with DAPI (in blue) to reveal nuclei.Supplementary Figure 2Total energy intake and body weight gain of endoN-treated and control mice during 1 month. Mice received 5 weekly bilateral stereotactic injections of endoN or vehicle (artificial cerebrospinal fluid) in the MBH under gaseous anesthesia. Animals were kept on standard diet. Food intake and body weight were monitored daily during one month after the first injection.Supplementary Figure 3Total energy intake and body weight gain of PST-1 KDMBH and control mice during 2 months. Mice received shRNA-expressing lentiviral vectors against Pst-1 or control vectors, by bilateral stereotactic injections in the MBH. After a 3-week recovery period, mice were further maintained on standard diet for an additional 2 month-period. Food intake and body weight were monitored daily during this period.Supplementary Figure 4Specificity and reversibility of *St8sia4* chromatin remodeling upon HFD exposure in MBH. A. Control ChIP with a non-specific isotype IgG antibody. B. Histones H3 and H4 post-translational modifications on the promoter of *St8sia4* were analyzed by ChIP. Chromatin extracts were obtained from MBH of mice fed either a standard diet (STD) or a HFD for 3 days (3-day HFD). C. Histones H3 and H4 post-translational modifications on the promoter of *St8sia2* were analyzed by ChIP. Chromatin extracts were obtained from MBH of mice fed either a standard diet (STD) or a HFD for 24 h (1-day HFD). D. Association of total histones H3 and H4 and of Pol2-S5P with the promoter of *St8sia2* was analyzed by ChIP on MBH extracts obtained after 1, 2 or 3 days of HFD exposure and compared to levels in MBH from mice fed a standard diet (STD). *n* = 6--8. Data are expressed as mean ± SEM. \**p* \< 0.05.
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![PSA removal in the hypothalamus accelerates the onset of DIO. (A) Picture showing the injection protocol of endoN in the mediobasal hypothalamus of mice fed either standard or a high-fat diet for one month. Five weekly bilateral injections of endoN (0.28 units/side) were performed. Control mice received artificial cerebrospinal fluid. (B) Effect of endoN injections on PSA level in the mediobasal hypothalamus, at the end of the treatment (*n* = 4 STD/aCSF; *n* = 5 STD/endoN; *n* = 5 HFD/aCSF; *n* = 6 HFD/endoN; \*: *p* \< 0.05; Mann Whitney test). (C) Body weight of endoN-treated and control mice fed a standard diet or a HFD for one month (*n* = 10 STD/aCSF; *n* = 9 STD/endoN; *n* = 13 HFD/aCSF; *n* = 14 HFD/endoN; \*\*: *p* \< 0.01. \*\*\*: *p* \< 0.001; two-way ANOVA and Bonferroni post-hoc test). (D) Body weight gain of endoN-treated and control mice fed a standard diet or a HFD for one month (\*\*: *p* \< 0.01. \*\*\*: *p* \< 0.001; Mann Whitney test). (E) Fat mass of endoN-treated and control mice fed a standard diet or a HFD for one month (\*\*: *p* \< 0.01. \*\*\*: *p* \< 0.001; Mann Whitney test). All results are mean ± SEM.](gr1){#fig1}

![Reduction of polysialylation in the hypothalamus increases the body weight gain on HFD. *St8sia4* knockdown mice, designated as PST-1 KD^MBH^ mice, were stereotactically injected in the mediobasal hypothalamus with ∼7.5 × 10^5^ shRNA-expressing lentiviral vectors against a Pst1 sequence. Control mice received lentiviral vectors targeting a non-mammalian sequence. (A) Effect of the lentiviral vectors-mediated RNA interference on relative mRNA expression of genes involved in the PSA signaling, assessed by RT-qPCR on mediobasal hypothalamus extracts from standard diet-fed mice (*n* = 4 control; *n* = 5 PST-1 KD^MBH^; \*: *p* \< 0.05; unpaired *t* test. (B) PSA level in the mediobasal hypothalamus of PST-1 KD^MBH^ mice fed a HFD for 2 months, compared to control mice (*n* = 9 control; *n* = 9 PST-1 KD^MBH^; \*: *p* \< 0.05; unpaired *t* test). (C) Kinetic of the body weight of PST-1 KD^MBH^ and control mice during 2-month HFD (\*: *p* \< 0.05, \*\*: *p* \< 0.01. \*\*\*: *p* \< 0.001; two-way ANOVA and Bonferroni post-hoc test). (D) Body weight gain of PST-1 KD^MBH^ and control mice after 2-month HFD (\*\*\*: *p* \< 0.001; unpaired *t* test). (E) Fat mass of PST-1 KD^MBH^ and control mice after 2 month-HFD (\*\*\*: *p* \< 0.001; unpaired *t* test). All results are mean ± SEM.](gr2){#fig2}

![HFD exposure activates *St8sia4* gene transcription. (A) Histones H3 and H4 post-translational modifications on the promoter of *St8sia4* were analyzed by ChIP. Chromatin extracts were obtained from MBH of mice fed either a standard diet (STD) or a HFD for 24 h (1-day HFD). (B) Association of total histones H3 and H4 and of Pol2-S5P with the promoter of *St8sia4* was analyzed by ChIP on MBH extracts obtained after 1, 2 or 3 days of HFD exposure and compared to levels in MBH of mice fed a standard diet (STD). (C) St8sia4 mRNA expression analyzed by RT-qPCR on MBH of mice fed a either a standard diet (STD) or a HFD for 1 or 3 day(s). STD: *n* = 9--12; HFD: *n* = 5--10. Data are expressed as mean ± SEM. \**p* \< 0.05.](gr3){#fig3}

![Histone acetyltransferases are recruited at the promoter of *St8sia4* upon HFD exposure. The recruitment of the histone acetyltransferases CBP, GCN5, MOF and TIP60 on the promoter of *St8sia4* was analyzed by ChIP. MBH chromatin extracts were prepared from mice either fed a standard diet (STD) or exposed to a HFD for 6 h (6-hr HFD) and 10 h (10-hr HFD). STD: *n* = 9--10; HFD 6 h: *n* = 9--10; HFD 10 h: *n* = 8. Data are expressed as mean ± SEM. \**p* \< 0.05.](gr4){#fig4}

![*Mof* knock-down impairs *St8sia4*-dependent polysialylation in the mediobasal hypothalamus. *Mof* knock-down was obtained by stereotaxic injection of lentiviral particles (∼1.0 × 10^6^ particles) containing *Mof* targeting shRNA (MOF KD^MBH^) or a shRNA targeting a non-mammalian RNA sequence (control) in the MBH. All analyses were performed 3 weeks after the delivery of lentiviral particles to the MBH. (A) RT-qPCR analysis of hypothalamic *Mof* mRNA levels in MOF KD^MBH^ and control mice. Control: *n* = 6; MOF KD^MBH^: *n* = 7. (B) ChIP analysis of H4K16Ac interaction with the St8sia4 promoter in the MBH of control and MOF KD^MBH^ mice after 24 h of HFD. Control: *n* = 7; MOF KD^MBH^: *n* = 7. (C) ChIP analysis of Pol2-S5P interaction with *St8sia4* promoter in control and MOF KD^MBH^ mice fed a HFD for 3 days. Control: *n* = 7; MOF KD^MBH^: *n* = 7. (D) RT-qPCR analysis of hypothalamic *St8sia4* mRNA levels in MOF KD^MBH^ and control mice. Control: *n* = 6; MOF KD^MBH^: *n* = 7. (E) PSA levels in control and MOF KD^MBH^ mice fed a HFD for 8 days. Control: *n* = 9; MOF KD^MBH^: *n* = 9. Data are expressed as mean ± SEM. \**p* \< 0.05.](gr5){#fig5}

![Lentiviral-mediated *Mof* knock-down in the hypothalamus accelerates the onset of DIO. (A) Energy intake of control and MOF KD^MBH^ mice fed a standard diet, 3 weeks after the injection of the shRNA-containing lentiviral particles. Control: *n* = 12; MOF KD^MBH^: *n* = 14. (B) Body weight of control and MOF KD^MBH^ mice fed a standard diet, 3 weeks after the injection of the shRNA-containing lentiviral particles. Control: *n* = 12; MOF KD^MBH^: *n* = 14. (C)--(H) Effect of *Mof* knock-down on food intake and body weight during short-term and long-term HFD. Control and MOF KD^MBH^ mice were fed a HFD for 8 weeks. (C) Analysis of the effect of *Mof* knock-down on the homeostatic feeding response to HFD. Daily energy intake of control and MOF KD^MBH^ mice was recorded for 8 days. (D) Cumulative energy intake over 8 days of HFD. (E) Body weight of control and MOF KD^MBH^ mice fed a HFD for 8 weeks. (F) Body weight gain of control and MOF KD^MBH^ mice after 8 weeks of HFD feeding. (G) Lean mass and fat mass of control and MOF KD^MBH^ mice after 8 weeks of HFD. (H) Total energy intake of control and MOF over 8 weeks of HFD feeding. Control: *n* = 7; MOF KD^MBH^: *n* = 8. Data are expressed as mean ± SEM. \**p* \< 0.05; \*\**p* \< 0.01; \*\*\**p* \< 0.001.](gr6){#fig6}

###### 

Antibodies used in Chromatin immunoprecipitation experiments.

  Target                                         Company      Reference
  ---------------------------------------------- ------------ ------------
  Histone H3                                     Millipore    17-10046
  Acetyl-Histone H3 (Lys9)                       Millipore    17-658
  Acetyl-Histone H3 (Lys14)                      Millipore    17-10051
  Acetyl-Histone H3 (Lys36)                      Millipore    07-540
  Trimethyl-Histone H3 (Lys27)                   Millipore    07-449
  Histone H4                                     Millipore    17-10047
  Monomethyl-Histone H4 (Lys20)                  Millipore    17-651
  Acetyl-Histone H4 (Lys16)                      Millipore    17-10101
  CBP                                            Santa Cruz   sc-369 X
  GCN5                                           Santa Cruz   sc-20698 X
  MOF                                            Bethyl       A300-992A
  TIP60                                          Santa Cruz   sc-5725 X
  RNA polymerase II CTD-phospho Ser5 (Pol2S5P)   Abcam        ab5131
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